Skip to content

Etiology of Endocarditis in Negative Blood Cultures

Etiology of Endocarditis in Negative Blood Cultures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02816307
Acronym
ENDOC
Enrollment
3033
Registered
2016-06-28
Start date
2013-06-07
Completion date
2022-10-26
Last updated
2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective Endocarditis (IE)

Brief summary

Infective endocarditis remains a serious disease that requires fast and specialized support in 2012. However, 24% of endocarditis unanswered etiology. The systematic use of new policy diagnosis, including (i) a systematic use of specific PCR techniques and (ii) the search for markers of inflammatory and tumoral diseases, should increase the number of positive etiological diagnosis of culture-negative samples. Secondly, because of the seriousness of the disease, the investigators were led to develop a new score: score for admission. This score, realized in less than 4 hours from the admission of the suspected patient with endocarditis, should allow for immediate probabilistic antibiotic treatment after completion of the diagnostic kit. The modified Duke score give its results in 4 to 7 days. With the score of admission thus diagnostic processes are accelerated and, where appropriate, empirical antibiotic therapy started. Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological identification of endocarditis. Secondary: Validate the admission score compared to the modified Duke score.

Interventions

OTHERblood samples

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient with endocarditis diagnostic kit prescribed * Patient is more than 18 years old * Patient who freely signed written informed consent. * Patient affiliated to a health assurance

Exclusion criteria

* Minor patient (\<18 years) * Patient pregnant or breastfeeding * Patient incapable or unable to consent * Private patient of liberty or under court order * Patient refusing to participate in the research

Design outcomes

Primary

MeasureTime frame
The percentage of patients with an etiological diagnosis of endocarditis6 years

Secondary

MeasureTime frame
The admission score1 day
the Duke score1day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026